UNSPSC 51442306: Indium in 111 satumomab pendetide or indium (111in) satumomab pendetide

This classification denotes a radioconjugate with the molecular formula C32H43N7O14.2H+.IN, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7V9926378A, a preparation that World Health Organization schedules in its Anatomical Therapeutic Chemical (ATC) Classification. Indium in 111 satumomab pendetide bears US NLM NCI C1469.

UNSPSC 51442306 Indium in 111 satumomab pendetide or indium (111in) satumomab pendetide is a Commodity code that nominally describes a radiopharmaceutical diagnostic agent. Recent state and local opportunities tagged under this code, however, show little alignment with the nominal scope. The four most recent opportunities posted between June and October 2026 include radiologic equipment and installation services (Maricopa County), X-ray equipment warranties (Escambia County Correction), X-ray system maintenance services (Broward County Aviation Department), and chemical supply (Pasco County, Florida). None of these solicitations involve the indium-111 radiopharmaceutical itself or related diagnostic imaging agents. The code shows minimal relevant recent activity for the specialized pharmaceutical product it nominally represents.

State and local procurement offices in Arizona, Florida, and Georgia jurisdictions have posted under this code during the past five months, but the misalignment between the code classification and the actual scope of work—ranging from capital equipment to chemical commodities to maintenance contracts—suggests either systematic misclassification or data-entry error rather than coherent procurement activity around indium satumomab pendetide. Businesses pursuing state and local contracts for radiopharmaceuticals or nuclear medicine diagnostics should verify current code assignments with individual procurement offices before bidding, as recent opportunities do not reflect the code's nominal product definition.